Chubb Limited
NYSE:CBInsurance - Property & Casualty
-$4.67 today
- Market cap
- $141.76B
- Beta
- 0.42
- P/E (TTM)
- 11.3
- EPS (TTM)
- $28.63
- Dividend yield
- 1.22%
Volume 1.99M
Average 1.63M
CB Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Chubb LimitedNYSE: CB
Research & Development · Q3 FY2026 · quarter ended Sep 2026
Research & development remains negative
Q3 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How CB compares with its peers on the latest reported figures
- CB's LTM Sep 2026 research & development of $0 is the highest of the 11 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for CB, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding CB) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for CB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 40.77B | 42.98B | 50.13B | 56.15B | 59.78B |
| Cost of Revenue | 29.44B | 32.15B | 36.29B | 39.98B | 42.18B |
| Gross Profit | 11.33B | 10.83B | 13.84B | 16.17B | 17.61B |
| Gross Margin | 27.8% | 25.2% | 27.6% | 28.8% | 29.4% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 3.14B | 3.4B | 4.01B | 4.38B | 4.5B |
| Operating Expenses | 1.54B | 4.35B | 4.31B | 4.72B | 4.56B |
| Depreciation & Amortization | 287M | 285M | 310M | 323M | 301M |
| EBITDA | 10.57B | 7.34B | 10.51B | 12.52B | 14.11B |
| EBITDA Margin | 25.9% | 17.1% | 21.0% | 22.3% | 23.6% |
| Operating Income | 9.79B | 6.49B | 9.53B | 11.46B | 13.04B |
| Operating Margin | 24.0% | 15.1% | 19.0% | 20.4% | 21.8% |
| Interest Income | 11M | 42M | 69M | 80M | 40M |
| Interest Expense | 492M | 570M | 672M | 741M | 764M |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 9.79B | 6.49B | 9.53B | 11.46B | 13.04B |
| Pre-Tax Margin | 24.0% | 15.1% | 19.0% | 20.4% | 21.8% |
| Income Tax Expense | 1.27B | 1.24B | 511M | 1.82B | 2.42B |
| Net Income | 8.53B | 5.25B | 9.03B | 9.27B | 10.31B |
| Net Margin | 20.9% | 12.2% | 18.0% | 16.5% | 17.2% |
| EPS (Basic) | 19.38 | 12.50 | 21.97 | 22.94 | 25.91 |
| EPS (Diluted) | 19.27 | 12.39 | 21.80 | 22.70 | 25.73 |
| Weighted Avg Shares | 439.97M | 419.78M | 410.85M | 408.5M | 396.5M |
| Weighted Avg Shares (Diluted) | 443.2M | 423.53M | 414.2M | 411.91M | 396.5M |
Chubb Limited
NYSE:CB
Intrinsic Alpha fair value
Locked
Current Price
$371.02
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.